Nurse Practitioner, Family · New Orleans, LA
NPI
1376890319
Since 2012
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
928 Hidalgo St
New Orleans, LA, 70124
Phone (504) 427-9118
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$509K
3,696 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Ingrid T Duffy prescribed most often to Medicare patients was Levothyroxine Sodium, with 204 prescriptions and refills. In total Ingrid T Duffy wrote 3,696 Medicare prescriptions that cost $509K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 204 | 204 | 19 | $5,792 |
| Sertraline Hcl Generic | 173 | 173 | 22 | $8,612 |
| Atorvastatin Calcium Generic | 168 | 168 | 21 | $12K |
| Amlodipine Besylate Generic | 165 | 165 | 19 | $4,781 |
| Gabapentin Generic | 108 | 108 | 13 | $3,981 |
| Quetiapine Fumarate Generic | 89 | 89 | 11 | $12K |
| Losartan Potassium Generic | 84 | 84 | Under 11 | $2,985 |
| Lisinopril Generic | 77 | 77 | 12 | $1,508 |
| Trazodone Hcl Generic | 69 | 69 | Under 11 | $1,727 |
| Lorazepam Generic | 64 | 67 | 20 | $904 |
| Furosemide Generic | 64 | 64 | 11 | $717 |
| Eliquis Apixaban | 59 | 59 | Under 11 | $34K |
| Metformin Hcl Generic | 59 | 59 | Under 11 | $1,529 |
| Oxycodone Hcl Generic | 52 | 52 | 13 | $1,776 |
| Tamsulosin Hcl Generic | 47 | 47 | Under 11 | $2,548 |
Brand drugs: 702 claims; generic drugs: 2,950 claims; opioid claims: 155.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ingrid T Duffy were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.